Inhibition of cell proliferation: A new role of liver X receptors

Clinical Lipidology

Volumn 6, Issue 2, 2011, Pages 137-141

  Bełtowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

cell cycle; cell proliferation; lipogenesis; liver X receptor

Indexed keywords

3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; ABC TRANSPORTER A1; ABC TRANSPORTER G1; CYCLIN A; FAS ANTIGEN; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PROTEIN TYROSINE PHOSPHATASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL LEVEL; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; LIPID STORAGE; LIPOGENESIS; NOTE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 79953815896     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.11.3     Document Type: Note

References (15)

1. Oosterveer MH, Grefhorst A, Groen AK, Kuipers F: The liver X receptor: control of cellular lipid homeostasis and beyond implications for drug design. Prog. Lipid Res. 49(4), 343-352 (2010).
2. Hu YW, Zheng L, Wang Q: Regulation of cholesterol homeostasis by liver X receptors. Clin. Chim. Acta 411(9-10), 617-625 (2010).
3. Baronowski M: Biological role of liver X receptors. J. Physiol. Pharmacol. 59(Suppl. 7), 31-55 (2008).
4. Gabbi C, Warner M, Gustafsson JA: Minireview: liver X receptor β: emerging roles in physiology and diseases. Mol. Endocrinol. 23(2), 129-136 (2009).
5. Blaschke F, Leppanen O, Takata Y et al.: Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ. Res. 95(12), E110-E123 (2004).
6. Geyeregger R, Shehata M, Zeyda M et al.: Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J. Leukoc. Biol. 86(5), 1039-1048 (2009).
7. Scoles DR, Xu X, Wang H et al.: Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein. Gynecol. Oncol. 116(1), 109-116 (2010).
8. Vedin LL, Lewandowski SA, Parini P, Gustafsson JA, Steffensen KR: The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 30(4), 575-579 (2009).
9. Kim KH, Lee GY, Kim JI, Ham M, Won Lee J, Kim JB: Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J. Lipid Res. 51(12), 3425-3433 (2010).
10. Bensinger SJ, Bradley MN, Joseph SB et al.: LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134(1), 97-111 (2008).
11. Choe SS, Choi AH, Lee JW et al.: Chronic activation of liver X receptor induces β-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic β-cells. Diabetes 56(6), 1534-1543 (2007).
12. Chuu CP, Lin HP: Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines. Anticancer Res. 30(9), 3643-3648 (2010).
13. -/- female mice. Proc. Natl Acad. Sci. USA 107(33), 14763-14768 (2010).
14. Kim HJ, Andersson LC, Bouton D, Warner M, Gustafsson JA: Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice. Proc. Natl Acad. Sci. USA 106(2), 558-563 (2009).
15. Bradford PG, Awad AB: Modulation of signal transduction in cancer cells by phytosterols. Biofactors 36(4), 241-247 (2010).